• Original Article
    1.
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
    V. Perkovic and OthersJun 13, 2019
  • Original Article
    2.
    Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Preliminary Report
    J.E. Layden and OthersSep 6, 2019
  • Original Article
    3.
    Zika Virus Disease in Colombia — Preliminary Report
    O. Pacheco and OthersJun 15, 2016
  • Original Article
    4.
    Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
    O. Distler and OthersJun 27, 2019
  • Original Article
    5.
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    M. Husain and OthersAug 29, 2019
  • Original Article
    6.
    Targeting Huntingtin Expression in Patients with Huntington’s Disease
    S.J. Tabrizi and OthersJun 13, 2019
  • Original Article
    7.
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    J.J.V. McMurray and OthersNov 21, 2019
  • Original Article
    8.
    Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
    K. Fischer and OthersJun 6, 2019
  • Original Article
    9.
    Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    T. Golan and OthersJul 25, 2019
  • Original Article
    10.
    Vitamin D Supplementation and Prevention of Type 2 Diabetes
    A.G. Pittas and OthersAug 8, 2019